Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Eur Arch Paediatr Dent ; 24(3): 321-326, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37314621

ABSTRACT

AIM: Revascularisation is a therapeutic approach for treatment of immature teeth with necrotic pulp. The conventional protocol includes application of triple antibiotic paste (TAP). The present study aimed to compare the efficacy of propolis and TAP as intra-canal medicaments for revascularisation of immature teeth in dogs. METHODOLOGY: This study was conducted on 20 immature (open-apex) canine teeth in mixed breaded dogs. First, the teeth were exposed to oral environment, followed by intra-canal cleaning and shaping 2 weeks later.. The teeth were divided into two groups. The TAP group received paste comprising of ciprofloxacin, metronidazole, and minocycline (at a concentration of 100 µg/mL), while propolis (15% w/v) was used in the other group. The revascularisation procedure was done by means of sodium hypochlorite, EDTA and distilled water as final irrigant. After dehumidifying and induction of bleeding, mineral trioxide aggregate (MTA) was applied At 6-month follow-up, radiographs were evaluated by two observers regarding root length and thickness, intra-canal calcification, periapical lesions, and apex formation. Data were analysed by the Chi-square and Fisher's exact tests. RESULTS: There was no significant difference between the TAP and propolis groups in root length or root thickness increase, calcification, related lesions, or apex formation (P > 0.05). CONCLUSION: Findings of the present study in experimental animals revealed that the efficacy of propolis as an intra-canal medicament is comparable to that of triple antibiotic paste for revascularisation therapy.


Subject(s)
Propolis , Tooth , Animals , Dogs , Humans , Anti-Bacterial Agents/therapeutic use , Propolis/therapeutic use , Minocycline , Metronidazole , Root Canal Irrigants/pharmacology , Root Canal Irrigants/therapeutic use , Drug Combinations
2.
Lupus ; 21(6): 616-24, 2012 May.
Article in English | MEDLINE | ID: mdl-22323339

ABSTRACT

Matrix metalloproteinase-2 (MMP-2) is a zinc dependent endonuclease that degrades type IV collagen, the major structural component of basement membranes. MMP-2 functional promoter polymorphism G1575A affects circulating level of MMP-2 and may be considered an important genetic determinant of cardiovascular disease (CVD) in systemic lupus erythematosus (SLE) patients. In this study, association between MMP-2 1575A allele with serum MMP-2, neopterin and lipid-lipoprotein levels and with SLE and developing CVD was investigated. The present case-control study consisted of 109 SLE patients with and without CVD (mean age, 35.6 years) and 101 gender- and age-matched, unrelated, healthy controls (mean age, 37.1 years) from the population in the west of Iran. MMP-2 1575G/A polymorphism was detected by polymerase chain reaction (restriction fragment length polymorphism) PCR-RFLP, serum MMP-2, neopterin and lipid levels were determined by enzyme-linked immunosorbent assay (ELISA), high-performance liquid chromatography (HPLC) and enzyme assay, respectively. The presence of MMP-2 G1575A allele was found to be associated with SLE and developed CVD (OR = 1.78, p = 0.029 and OR = 3.43, p = 0.025, respectively). The SLE patients with MMP-2 A (G/A + A/A) allele had higher MMP-2 activity (301 ± 166 vs. 194 ± 35.5, p = 0.002), neopterin (29.4 ± 39.4 vs. 7.3 ± 4.6, p = 0.005), LDL-C (120 ± 25.7 vs. 87 ± 39.3, p = 0.045) and lower HDL-C (39.6 ± 11 vs. 45.9 ± 11.8, p = 0.031) levels than the control subjects. There was a significantly positive correlation between MMP-2 level with neopterin, total cholesterol and TG levels and negative correlation with HDL-C level in SLE patients with CVD. MMP-2 G1575A allele may be a risk factor for SLE. The carriers of this allele have high levels of MMP-2, neopterin, total cholesterol and TG and lower levels of HDL, thus, they are more likely to develop heart disease.


Subject(s)
Cardiovascular Diseases/epidemiology , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/genetics , Matrix Metalloproteinase 2/blood , Matrix Metalloproteinase 2/genetics , Polymorphism, Genetic/genetics , Promoter Regions, Genetic/genetics , Adolescent , Adult , Aged , Alleles , Case-Control Studies , Cholesterol/blood , Female , Humans , Iran , Lupus Erythematosus, Systemic/complications , Male , Middle Aged , Neopterin/blood , Risk Factors , Triglycerides/blood , Young Adult
3.
Acta Cytol ; 41(3): 835-8, 1997.
Article in English | MEDLINE | ID: mdl-9167710

ABSTRACT

BACKGROUND: Cardiac rhabdomyoma is a very common benign tumor in infants and children. It can be confused clinically with a malignant tumor. CASE: A 6-year-old girl was admitted with a chief complaint of breathlessness. Chest roentgenography revealed cardiomegaly. Echocardiography showed a right atrial mass. Intraoperative fine needle aspiration showed groups of large, polygonal cells with granular, vacuolated cytoplasm. Rarely were intranuclear inclusions observed. CONCLUSION: The cytologic findings were characteristic of rhabdomyoma.


Subject(s)
Heart Neoplasms/diagnosis , Rhabdomyoma/diagnosis , Biopsy, Needle/methods , Child , Female , Heart Neoplasms/pathology , Humans , Intraoperative Period , Rhabdomyoma/pathology
SELECTION OF CITATIONS
SEARCH DETAIL